Adherex Technologies Inc. is a biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics. Our mission is to become an industry leader in addressing the unmet medical needs of cancer patients. ) currently in Phase II trials; eniluracil, which is expected to be in Phase III trials as early as 2007; and sodium thiosulfate (STS).
Adherex Technologies Inc. is Ottawa-based company (Ontario, Canada) with a phone number 6137388000. Our data show that the company is located at the address: 600 Peter Morand Crescent. The company has a web site: www.adherex.com.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.